Ibuprofen for COVID-19 symptoms?

Prof Parastou Donyai

writer

Prof Parastou Donyai

Professor and Director of Pharmacy Practice, University of Reading

Claim CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

Prof Parastou Donyai

There’s been some confusion recently on whether we should or shouldn’t take ibuprofen to treat symptoms of COVID-19 – especially after the World Health Organization (WHO) changed its stance. After initially recommending people avoid taking ibuprofen to treat symptoms of the new coronavirus disease, as of March 19 the WHO now does not recommend avoiding ibuprofen to treat COVID-19 symptoms.

The confusion began after France’s Minister of Solidarity and Health Oliver Véran announced on Twitter that taking anti-inflammatory drugs (such as ibuprofen or cortisone) could be a factor in worsening a COVID-19 infection. He recommended that paracetamol should be taken instead to treat the associated fever.

At the moment, the NHS only recommends taking paracetamol for COVID-19 symptoms, even though it admits there is no strong evidence showing ibuprofen worsens symptoms. The BMJ also states that ibuprofen should be avoided when managing COVID-19 symptoms.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Nicole Goh

A/Prof Nicole Goh

Detection, Assessment and Management of Pulmonary Fibrosis

A/Prof Robyn Saw

A/Prof Robyn Saw

Practical Melanoma Management for GPs

Dr Bobby Chan

Dr Bobby Chan

Preventing Renal Failure in Type 2 Diabetes – New Options

Dr Victoria Hayes

Dr Victoria Hayes

Management of Post-Vaccination Reactions

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Prof Parastou Donyai

writer

Prof Parastou Donyai

Professor and Director of Pharmacy Practice, University of Reading

Test your knowledge

Recent articles

Latest GP poll

In your opinion, will the mass resignation of psychiatrists in NSW prompt government action?

Yes

0%

No

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Get ahead of your learning in 2025 and earn up to 24 hours of CPD across all three learning categories (EA, RP & MO).